# Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer

> **NCT00602797** · PHASE2 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 20 (actual)

## Conditions studied

- Recurrent Non-Small Cell Lung Carcinoma
- Stage IV Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** Paclitaxel
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration
- **DRUG:** Vinorelbine Tartrate

## Key facts

- **NCT ID:** NCT00602797
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12-17
- **Primary completion:** 2014-08-01
- **Final completion:** 2014-08-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00602797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00602797, "Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00602797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*